17-17793779-CCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_030665.4(RAI1):​c.867_872dupGCAGCA​(p.Gln290_Gln291dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,357,582 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q291Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 0)
Exomes 𝑓: 0.00097 ( 0 hom. )

Consequence

RAI1
NM_030665.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.36

Publications

8 publications found
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]
RAI1 Gene-Disease associations (from GenCC):
  • Smith-Magenis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Potocki-Lupski syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_030665.4
BP6
Variant 17-17793779-C-CCAGCAG is Benign according to our data. Variant chr17-17793779-C-CCAGCAG is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 589308.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00279 (220/78922) while in subpopulation AFR AF = 0.00634 (151/23834). AF 95% confidence interval is 0.00551. There are 1 homozygotes in GnomAd4. There are 88 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 220 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAI1NM_030665.4 linkc.867_872dupGCAGCA p.Gln290_Gln291dup disruptive_inframe_insertion Exon 3 of 6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkc.867_872dupGCAGCA p.Gln290_Gln291dup disruptive_inframe_insertion Exon 3 of 6 1 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1
RAI1ENST00000395774.1 linkc.867_872dupGCAGCA p.Gln290_Gln291dup disruptive_inframe_insertion Exon 2 of 2 2 ENSP00000379120.1 A8MXE8

Frequencies

GnomAD3 genomes
AF:
0.00278
AC:
219
AN:
78832
Hom.:
1
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00632
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00187
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00123
Gnomad FIN
AF:
0.000495
Gnomad MID
AF:
0.0169
Gnomad NFE
AF:
0.00126
Gnomad OTH
AF:
0.00282
GnomAD4 exome
AF:
0.000968
AC:
1238
AN:
1278660
Hom.:
0
Cov.:
38
AF XY:
0.000965
AC XY:
610
AN XY:
632422
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00458
AC:
131
AN:
28588
American (AMR)
AF:
0.00114
AC:
36
AN:
31710
Ashkenazi Jewish (ASJ)
AF:
0.0000428
AC:
1
AN:
23378
East Asian (EAS)
AF:
0.000268
AC:
5
AN:
18624
South Asian (SAS)
AF:
0.000932
AC:
52
AN:
55802
European-Finnish (FIN)
AF:
0.000195
AC:
9
AN:
46186
Middle Eastern (MID)
AF:
0.00103
AC:
5
AN:
4866
European-Non Finnish (NFE)
AF:
0.000935
AC:
951
AN:
1017548
Other (OTH)
AF:
0.000924
AC:
48
AN:
51958
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.365
Heterozygous variant carriers
0
67
134
200
267
334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00279
AC:
220
AN:
78922
Hom.:
1
Cov.:
0
AF XY:
0.00235
AC XY:
88
AN XY:
37510
show subpopulations
African (AFR)
AF:
0.00634
AC:
151
AN:
23834
American (AMR)
AF:
0.00187
AC:
11
AN:
5874
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1968
East Asian (EAS)
AF:
0.00
AC:
0
AN:
748
South Asian (SAS)
AF:
0.00122
AC:
1
AN:
818
European-Finnish (FIN)
AF:
0.000495
AC:
3
AN:
6066
Middle Eastern (MID)
AF:
0.0181
AC:
3
AN:
166
European-Non Finnish (NFE)
AF:
0.00126
AC:
48
AN:
37988
Other (OTH)
AF:
0.00278
AC:
3
AN:
1080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
2
Bravo
AF:
0.00161

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RAI1: BS1, BS2 -

Jul 06, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Nov 03, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RAI1-related disorder Benign:1
Jul 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.4
Mutation Taster
=83/17
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371983878; hg19: chr17-17697093; API